S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Heron Therapeutics Discloses New Proprietary Intravenous Formulation of NK-1 Receptor Antagonist for Prevention of CINV|
|OPKO Licensee TESARO Submits New Drug Application for Rolapitant|
|CANDA NK-2 Files Motion to Dismiss Patent Infringement Suit (2014/10/22)|
|HollyFrontier Corporation Reports Quarterly Net Income|
|INNATE PHARMA : INITIATION OF A PHASE I CLINICAL TRIAL OF LIRILUMAB IN COMBINATION WITH ELOTUZUMAB (2014/10/1)|
|Heron Therapeutics Announces Third Quarter and Year-to-Date 2014 Financial Results and Corporate Highlights|
|TESARO Announces Submission of Rolapitant New Drug Application (NDA) to U.S. Food and Drug Administration|
|Bloomingdale’s Premieres New Location in Stanford, CA (2014/10/8)|
|Compugen Discloses Successful Validation Results for Novel B7/CD28–like Cancer Immunotherapy Target Candidate|
|Lazard Ltd Reports Third-Quarter and Nine-Month 2014 Results (2014/10/23)|
Click above to view more mutual fund data and stats for nk - Imerys.